Detalhe da pesquisa
1.
Efficacy of R-BAC in relapsed, refractory mantle cell lymphoma post BTK inhibitor therapy.
Br J Haematol
; 189(4): 684-688, 2020 05.
Artigo
Inglês
| MEDLINE | ID: mdl-32011729
2.
Response to tyrosine kinase inhibitors in myeloid neoplasms associated with PCM1-JAK2, BCR-JAK2 and ETV6-ABL1 fusion genes.
Am J Hematol
; 95(7): 824-833, 2020 07.
Artigo
Inglês
| MEDLINE | ID: mdl-32279331
3.
The management of myelofibrosis: A British Society for Haematology Guideline.
Br J Haematol
; 204(1): 136-150, 2024 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38037886
4.
Diagnosis and evaluation of prognosis of myelofibrosis: A British Society for Haematology Guideline.
Br J Haematol
; 204(1): 127-135, 2024 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37932932
5.
Diagnosis and evaluation of prognosis of myelofibrosis: a British Society for Haematology guideline
Br. j. haematol
; 204(1): 127-134, 20240101.
Artigo
Inglês
| BIGG | ID: biblio-1537641
6.
The management of myelofibrosis: a British Society for Haematology guideline
Br. j. haematol
; 204(1): 136-150, 20240101.
Artigo
Inglês
| BIGG | ID: biblio-1537635
7.
Results of a national UK physician reported survey of COVID-19 infection in patients with a myeloproliferative neoplasm.
Leukemia
; 35(8): 2424-2430, 2021 08.
Artigo
Inglês
| MEDLINE | ID: mdl-33580204